Rt. Woodburn et al., Intense p53 staining is a valuable prognostic indicator for poor prognosisin medulloblastoma/central nervous system primitive neuroectodermal tumors, J NEURO-ONC, 52(1), 2001, pp. 57-62
Intense p53 immunostaining may predict for a poor prognosis in central nerv
ous system primitive neuroectodermal tumor of childhood.
Background: Medulloblastoma is a common childhood primary brain tumor. Pote
ntial prognostic indicators for patients with local disease are age, extent
of resection, and gender. However, none of these are well established. Imm
unohistologic staining is a potentially useful means to identify high-risk
patients. The purpose of this clinical pathologic study was to investigate
the prognostic significance of GFAP, synaptophysin, Ki-67, and p53 immunost
aining in medulloblastoma/central nervous system primitive neuroectodermal
tumors (CNS PNETs.)
Materials and methods: The records of 40 patients with CNS PNETs were revie
wed. Their surgical specimens were immunostained for p53, glial fibrillary
acidic protein (GFAP), synaptophysin, and Ki-67. The p53 specimens were sco
red blindly for the intensity of staining of nuclei (intense vs weak) and t
he quantity of cells stained. The Ki-67, GFAP, and synaptophysin specimens
were analyzed for quantity of cells stained.
Results: Ten patients' specimens stained intensely for the p53 protein. Ele
ven had weakly staining nuclei. Nineteen specimens had no staining. The pat
ients with specimens that stained intensely had a statistically significant
decreased disease free survival (P = 0.03). Mere presence or quantity of p
53 nuclear staining did not correlate with disease free survival. Immunohis
tochemical staining for Ki-67, GFAP, and synaptophysin did not correlate wi
th disease free survival. Clinical parameters of age, gender, and extent of
resection also did not approach statistical break significance for disease
free survival.
Conclusion: Intense nuclear staining for p53 was the only variable in this
clinical pathologic study that reached statistical significance for disease
free survival. This suggests that intense staining for p53 may be the most
important prognostic indicator for non-metastatic CNS PNETs. p53 Immunosta
ining with antibodies against p53 in CNS PNETs should be studied in a multi
-institutional setting with larger numbers of patients.